Personalized Medicine in Cystic Fibrosis
A genetic disease called cystic fibrosis results from mutations in the gene that codes for a protein called CFTR, which regulates the body’s ability to absorb and secrete salts and water[30]. The drug is designed to target one of several faulty CFTR proteins in patients, resulting in meaningful and long-term improvements in lung function [31].
Personalized medicine in the COVID-19
In the ongoing global pandemic of Corona virus, personalized medicine is currently being utilized to aid in the prevention of its spread. Scientists are now utilizing artificial intelligence and the automated patient model to identify COVID-19 high-risk genes.
Several studies are studying whether Corona virus can be treated with drugs designed for other diseases. COVID-19 patients who suffer complications such as sepsis might benefit from these drugs as they can be used to develop new clinical strategies to improve their survival rates. In patients with serious COVID-19 reactions, data-driven observations aid in the identification and characterization of underlying and related disorders, as well as problems related to such conditions.